Shilpa Medicare Ltd (SHILPAMED) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 780523, "name": "Shilpa Medicare", "stock_name": "Shilpa Medicare", "full_name": "Shilpa Medicare Ltd", "name_url": "stocks-analysis/shilpa-medicare", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "337.15", "chg": 22.7, "chgp": "7.22%", "dir": 1, "prev_price": "314.45", "mcapval": "6,594.04 Cr", "mcap": "Small Cap", "scripcode": 530549, "symbol": "SHILPAMED", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE790G01031", "curr_date": "Feb 09", "curr_time": "", "bse_nse_vol": "21.62 lacs", "exc_status": "Active", "traded_date": "Feb 09, 2026", "traded_date_str": "2026 02 09", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shilpa-medicare-780523-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Shilpa Medicare Ltd Hits Intraday High with 7.33% Surge on 9 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-hits-intraday-high-with-733-surge-on-9-feb-2026-3828494", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_priceRelatedfactors_3828494.png", "date": "2026-02-09 10:13:00", "description": "Shilpa Medicare Ltd recorded a robust intraday performance on 09 Feb 2026, surging to a day’s high of Rs 359.95, marking a significant 7.33% gain. The pharmaceutical and biotechnology company outpaced its sector and the broader market, reflecting heightened trading activity and volatility." }, { "title": "Shilpa Medicare Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3828129", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_gapup_3828129.png", "date": "2026-02-09 09:31:03", "description": "Shilpa Medicare Ltd commenced trading today with a significant gap up, opening 14.47% higher than its previous close, signalling robust positive sentiment in the Pharmaceuticals & Biotechnology sector. This strong start was accompanied by heightened volatility and outperformance relative to both its sector and the broader market indices." }, { "title": "Shilpa Medicare Ltd Reports Very Positive Quarterly Financial Performance Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-reports-very-positive-quarterly-financial-performance-amid-sector-challenges-3827719", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_fintrenddot_3827719.png", "date": "2026-02-09 08:00:25", "description": "Shilpa Medicare Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, shifting its financial trend from positive to very positive. The pharmaceutical and biotechnology company recorded its highest quarterly net sales and profitability metrics in recent history, signalling a potential turnaround despite a challenging broader market environment." }, { "title": "Shilpa Medicare Gains 8.45%: 4 Key Factors Driving the Weekly Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-gains-845-4-key-factors-driving-the-weekly-surge-3826351", "imagepath": "", "date": "2026-02-07 15:06:55", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Stock opens lower at Rs.287.20 amid broader market weakness</p>\n <p><strong>3 Feb:</strong> Strong gap up opening, surging 7.94% intraday to Rs.310</p>\n <p><strong>6 Feb:</strong> Q3 FY26 results released; technical upgrade and rating change announced</p>\n <p><strong>6 Feb:</strong> Week closes at Rs.314.45, up 8.45% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.289.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div ..." }, { "title": "Are Shilpa Medicare Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-shilpa-medicare-ltd-latest-results-good-or-bad-3824852", "imagepath": "", "date": "2026-02-06 19:24:51", "description": "Shilpa Medicare Ltd's latest financial results for Q3 FY26 reflect a strong operational performance, with net sales reaching ₹409.73 crores, marking the highest quarterly figure in the company's history. This represents a year-on-year growth of 28.32% and a quarter-on-quarter increase of 10.75%. The net profit for the quarter stood at ₹44.58 crores, showing a year-on-year growth of 40.28% and a slight quarter-on-quarter increase of 1.16%. \n\nThe operating margin for Q3 FY26 was reported at 27.90%, which is the highest in eight quarters, indicating effective cost management despite a marginal decline from the previous quarter's 29.27%. However, the profit after tax margin of 10.88% has decreased from 11.91% in Q2 FY26, raising concerns about sustainability.\n\nDespite these positive operational metrics, the company continues to face challenges regarding capital efficiency, as indicated by a return on equity (RO..." }, { "title": "Shilpa Medicare Q3 FY26: Strong Momentum Masks Underlying Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/shilpa-medicare-q3-fy26-strong-momentum-masks-underlying-concerns-3824751", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicare_quaterlyResult_3824751.png", "date": "2026-02-06 17:20:21", "description": "Shilpa Medicare Ltd., a Raichur-based pharmaceutical company specialising in active pharmaceutical ingredients (APIs), formulations, and contract development, reported consolidated net profit of ₹44.58 crores for Q3 FY26 (October-December 2025), marking a marginal 1.16% quarter-on-quarter increase but a robust 40.28% year-on-year surge. Despite the impressive earnings growth, the stock has languished, trading at ₹318.00 with a market capitalisation of ₹6,122 crores, down 36.60% from its 52-week high of ₹501.60." }, { "title": "Shilpa Medicare Ltd Upgraded to Sell on Technical Improvements and Valuation Appeal", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-upgraded-to-sell-on-technical-improvements-and-valuation-appeal-3823759", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_mojoScore_3823759.png", "date": "2026-02-06 08:11:27", "description": "Shilpa Medicare Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 5 February 2026. This change reflects nuanced shifts across four critical parameters: quality, valuation, financial trend, and technicals. Despite persistent challenges in long-term fundamentals, recent technical improvements and valuation metrics have prompted a more favourable outlook, albeit still cautious." }, { "title": "Shilpa Medicare Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-technical-momentum-shifts-amid-mixed-market-signals-3823638", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_technicaldot_3823638.png", "date": "2026-02-06 08:02:12", "description": "Shilpa Medicare Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook, reflecting nuanced changes in key indicators such as MACD, RSI, and moving averages. Despite a modest daily gain of 1.12%, the pharmaceutical company’s technical profile remains cautious, with mixed signals across weekly and monthly timeframes suggesting a complex near-term trajectory." }, { "title": "Shilpa Medicare Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3817874", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_gapup_3817874.png", "date": "2026-02-03 09:51:19", "description": "Shilpa Medicare Ltd commenced trading on 3 Feb 2026 with a notable gap up, opening 7.94% higher than its previous close, signalling a strong start driven by positive market momentum within the Pharmaceuticals & Biotechnology sector." } ], "total": 371, "sid": "780523", "stock_news_url": "https://www.marketsmojo.com/news/shilpa-medicare-780523" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "06-Feb-2026", "details": "Analyst/Investor Call -Call Recording", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation", "datetime": "06-Feb-2026", "details": "Announcement under regulation 30 (LODR) - Investor Presentation", "source": "BSE" }, { "caption": "Announcement Under Regulation 30 (LODR)-Meeting Updates", "datetime": "06-Feb-2026", "details": "Integrated financials for third quarter and nine months ended 31 December 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has declared <strong>100%</strong> dividend, ex-date: 17 Sep 25", "dt": "2025-09-17", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has announced <strong>1:2</strong> stock split, ex-date: 06 Nov 15", "dt": "2015-11-06", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 03 Oct 25", "dt": "2025-10-03", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Stock opens lower at Rs.287.20 amid broader market weakness

3 Feb: Strong gap up opening, surging 7.94% intraday to Rs.310

6 Feb: Q3 FY26 results released; technical upgrade and rating change announced

6 Feb: Week closes at Rs.314.45, up 8.45% for the week

Week Open

Rs.289.95

Week Close

Read full news article

Are Shilpa Medicare Ltd latest results good or bad?

2026-02-06 19:24:51

Shilpa Medicare Ltd's latest financial results for Q3 FY26 reflect a strong operational performance, with net sales reaching ₹409.73 crores, marking the highest quarterly figure in the company's history. This represents a year-on-year growth of 28.32% and a quarter-on-quarter increase of 10.75%. The net profit for the quarter stood at ₹44.58 crores, showing a year-on-year growth of 40.28% and a slight quarter-on-quarter increase of 1.16%. The operating margin for Q3 FY26 was reported at 27.90%, which is the highest in eight quarters, indicating effective cost management despite a marginal decline from the previous quarter's 29.27%. However, the profit after tax margin of 10.88% has decreased from 11.91% in Q2 FY26, raising concerns about sustainability. Despite these positive operational metrics, the company continues to face challenges regarding capital efficiency, as indicated by a return on equity (RO...

Read full news article

Shilpa Medicare Q3 FY26: Strong Momentum Masks Underlying Concerns

2026-02-06 17:20:21

Shilpa Medicare Ltd., a Raichur-based pharmaceutical company specialising in active pharmaceutical ingredients (APIs), formulations, and contract development, reported consolidated net profit of ₹44.58 crores for Q3 FY26 (October-December 2025), marking a marginal 1.16% quarter-on-quarter increase but a robust 40.28% year-on-year surge. Despite the impressive earnings growth, the stock has languished, trading at ₹318.00 with a market capitalisation of ₹6,122 crores, down 36.60% from its 52-week high of ₹501.60.

Read full news article

Shilpa Medicare Ltd Upgraded to Sell on Technical Improvements and Valuation Appeal

2026-02-06 08:11:27

Shilpa Medicare Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 5 February 2026. This change reflects nuanced shifts across four critical parameters: quality, valuation, financial trend, and technicals. Despite persistent challenges in long-term fundamentals, recent technical improvements and valuation metrics have prompted a more favourable outlook, albeit still cautious.

Read full news article

Shilpa Medicare Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-06 08:02:12

Shilpa Medicare Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook, reflecting nuanced changes in key indicators such as MACD, RSI, and moving averages. Despite a modest daily gain of 1.12%, the pharmaceutical company’s technical profile remains cautious, with mixed signals across weekly and monthly timeframes suggesting a complex near-term trajectory.

Read full news article

Shilpa Medicare Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment

2026-02-03 09:51:19

Shilpa Medicare Ltd commenced trading on 3 Feb 2026 with a notable gap up, opening 7.94% higher than its previous close, signalling a strong start driven by positive market momentum within the Pharmaceuticals & Biotechnology sector.

Read full news article